New patent expiration for Padagis Us drug CLINDESSE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for CLINDESSE
Annual Drug Patent Expirations for CLINDESSE

Clindesse is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

CLINDESSE drug price trends.

Drug patent litigation for CLINDESSE.

This drug has forty-four patent family members in twenty-one countries.

The generic ingredient in CLINDESSE is clindamycin phosphate. One supplier is listed for this compound. Additional details are available on the clindamycin phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top